

[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI

[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
Raghuram Selvaraju Reiterated (SPRB) at Hold on, May 14th, 2024
Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Spruce Biosciences, Inc." (SPRB) at Hold on, May 14th, 2024.
Raghuram has made no other calls on SPRB in the last 4 months.
There are 5 other peers that have a rating on SPRB. Out of the 5 peers that are also analyzing SPRB, 4 agree with Raghuram's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Aydin Huseynov of "Ladenburg Thalmann" Downgraded from Strong Buy to Hold on, Thursday, March 14th, 2024
- Evan Wang of "Guggenheim" Downgraded from Strong Buy to Hold on, Thursday, March 14th, 2024
- Gregory Renza of "RBC Capital" Downgraded from Buy to Hold and Decreased Target to $2 on, Thursday, March 14th, 2024
- Joseph Schwartz of "Leerink Partners" Downgraded from Buy to Hold and Decreased Target to $2 on, Thursday, March 14th, 2024
This is the rating of the analyst that currently disagrees with Raghuram
- Jonathan Wolleben of "JMP Securities" Maintained at Buy with Decreased Target to $3 on, Thursday, March 14th, 2024
Contributing Sources